Triptans are used to relieve migraine attacks, being an agonist on 5-hydroxytryptamine receptors (5-HT1B/1D), they can cause the constriction of dilated cranial arteries and the inhibition of CGRP release [20]. This evidence concerns the gene HTR1B and migraine disorder.